Endpoints News
Merck KGaA's clients are stockpiling Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T Wed Th F
13 May, 2026
US Pharma and Biotech Summit - May 14, 2026
Policy shifts, regulatory unknowns, and a dealmaking environment that won’t sit still — US biopharma is navigating serious uncertainty. Join FT Live and Endpoints News for the conversations that will define what comes next.
presented by Parexel Biotech
Mov­ing be­yond sci­ence to ac­cess: Solv­ing the ac­cess im­per­a­tive
news
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
ENDPOINTS NEWS
Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost
ENDPOINTS NEWS
 
Iran war disruptions begin to emerge upstream of the pharma supply chain
ENDPOINTS NEWS
FDA Commissioner Makary resigns
ENDPOINTS NEWS
Endpoints webinars
May 20
11:00 am ET
Application of Simple Western to analysis of antibody target affinity and specificity
Bio-Techne
LGBTQ+ LEADERSHIP IN 2026
LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.
ENDPOINTS PHARMA
EU reaches provisional deal on Critical Medicines Act
ENDPOINTS NEWS
Five burning questions for Isomorphic after its mammoth $2B+ raise
ENDPOINTS NEWS
Bayer to make 'careful but aggressive' return to pharma M&A, CEO says
ENDPOINTS NEWS
in case you missed it
1.
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
ENDPOINTS NEWS
2.
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
ENDPOINTS NEWS
3.
News Briefing
Alkermes' narcolepsy Phase 3 success; Boehringer's antibody deal
ENDPOINTS NEWS
4.
Flagship startup says it has solved non-viral gene therapy in monkeys, but details remain murky
ENDPOINTS NEWS
5.
How an ‘impossible’ idea led to a pancreatic cancer breakthrough
THE NEW YORK TIMES
6.
Most dementia patients have multiple brain diseases. How should they be treated?
Science Magazine
Reynald Castaneda
.

One more day until the US Pharma and Biotech Summit with our friends at the Financial Times. Check out the agenda here and details on how to attend in person in New York or virtually. See you then! 

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter